Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jan 29;5(9):a017285.
doi: 10.1101/cshperspect.a017285.

The Status of RPE65 Gene Therapy Trials: Safety and Efficacy

Affiliations
Review

The Status of RPE65 Gene Therapy Trials: Safety and Efficacy

Eric A Pierce et al. Cold Spring Harb Perspect Med. .

Abstract

Several groups have reported the results of clinical trials of gene augmentation therapy for Leber congenital amaurosis (LCA) because of mutations in the RPE65 gene. These studies have used subretinal injection of adeno-associated virus (AAV) vectors to deliver the human RPE65 cDNA to the retinal pigment epithelial (RPE) cells of the treated eyes. In all of the studies reported to date, this approach has been shown to be both safe and effective. The successful clinical trials of gene augmentation therapy for retinal degeneration caused by mutations in the RPE65 gene sets the stage for broad application of gene therapy to treat retinal degenerative disorders.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Frames from an intraoperative video of surgical delivery of AAV2-hRPE65.v2 in a Phase I/II clinical trial at CHOP. (A) A drop of dense Perfluoron liquid is layered onto the fovea to buttress it during the retinal detachment. (B) The subretinal injection cannula is opposed to the neural retina. Injection of the excipient (containing the AAV) causes a separation between the neural retina and the underlying retinal pigment epithelium (i.e., a localized retinal detachment). (C) A view of the detached region of the retina at lower magnification. The optic disk is visible and the detachment includes the superior arcade and extends through the fovea. A few small bubbles, introduced with the AAV, are now visible in the subretinal space.

References

    1. Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kelling SE, Anand V, Zeng Y, Maguire AM, et al. 2001. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 28: 92–95. - PubMed
    1. Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV, Bennicelli J, Dejneka NS, Pearce-Kelling SE, Maguire AM, Palczewski K, et al. 2005. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther 12: 1072–1082. - PMC - PubMed
    1. Aleman TS, Jacobson SG, Chico JD, Scott ML, Cheung AY, Windsor EA, Furushima M, Redmond TM, Bennett J, Palczewski K, et al. 2004. Impairment of the transient pupillary light reflex in Rpe65−/− mice and humans with Leber congenital amaurosis. Invest Ophthalmol Vis Sci 45: 1259–1271. - PubMed
    1. Alexander JJ, Umino Y, Everhart D, Chang B, Min SH, Li Q, Timmers AM, Hawes NL, Pang JJ, Barlow RB, et al. 2007. Restoration of cone vision in a mouse model of achromatopsia. Nat Med 13: 685–687. - PMC - PubMed
    1. Ali RR, Sarra GM, Stephens C, Alwis MD, Bainbridge JW, Munro PM, Fauser S, Reichel MB, Kinnon C, Hunt DM, et al. 2000. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet 25: 306–310. - PubMed

MeSH terms